M42 and 10XREVIV plan GLP-1 nutrition clinical study
Arabian Post Staff -Dubai Abu Dhabi-based M42 research subsidiary IROS and 10XREVIV have announced a clinical study to test whether personalised nutrition can improve health outcomes for patients taking GLP-1 medicines for weight management. The planned research will compare 10XREVIV’s precision nutrition system combined with standard medical care against standard care alone, examining whether…
We haven't written up this one. Arabian Post has the full story — the link below goes straight to it.
